Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler

Understanding a Brain Tumor Diagnosis

Yale Cancer Center

M. Barden

The Roadmap for "Cancer Neuroscience": Implications for Oncology and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Hervey-Jumper

Multidisciplinary Approach to Diffuse Midline Glioma

Andrea Carai

Approach to Pediatric Gliomas in the Molecular Era

Lauren Weintraub

Primary Brain Tumors: Gliomas - Astrocytomas

UNC Lineberger Comprehensive Cancer Center

D. Higgins

Vorasidenib for Low Grade Gliomas

Stanford Medicine

T. Cao

Low Grade Gliomas: Current Strategies and Considerations

Simon Bailey

BRAF/MEK Targeted Therapy in Adult and Pediatric Glioma: Insights an…

Johns Hopkins

K. Schreck

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

E. Galanis

BRAF in the MAPK Pathway for Pediatric Low-Grade Glioma: Current Tes…

Avani Mangoli

Advances in Immunotherapy for Glioblastoma

San Francisco Neurological Society

O. Bloch

Diffuse Midline Gliomas H3K27-Altered

Enrico Franceschi

Overview of DMG H3K27-Altered: Case Presentations and Treatment Appr…

Margaret Johnson

Integrated Molecular Profiling in the Diagnosis of Gliomas: The Role…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

M. Nasrallah

MAPK Pathway Alterations in Childhood Cancer With a Focus on Pediatr…

Enrico Opocher